Juno’s lasting legacy: How the cell therapy juggernaut influenced biotech in Seattle and beyond When Juno Therapeutics launched in 2013, cell therapy was a nascent field. Early clinical studies were showing dramatic rates of… Read More
Bill Gates and Jeff Bezos-backed cancer detection company Grail, led by ex-Juno CEO, files for IPO Cancer detection startup Grail today filed to go public as the Silicon Valley biotech aims to raise more funding for… Read More
Tech Moves: Ex-Juno CEO Hans Bishop takes over at Grail; Amazon Business chief departs; Shyft co-founder jumps to Ally; and more — The former head of Juno Therapeutics, Hans Bishop, signed on as CEO of Grail, a Bay Area biotech focused… Read More
Grail raises $300M for cancer detection tools, boosting total investment to $1.5B News Brief: Grail, a biotech company with early backing from Microsoft co-founder Bill Gates and Amazon founder Jeff Bezos, says… Read More
Bill Gates and Jeff Bezos invest in Grail, Illumina’s $100M cancer testing venture One of the giants of gene sequencing, Illumina, has spun off a new $100 million company called Grail to create… Read More
